Pharmacogenetic study on the effect of rivastigmine on PS2 and APOE genes in Iranian Alzheimer patients

Dementia and Geriatric Cognitive Disorders Extra

Volumn 1, Issue 1, 2011, Pages 180-189

  Zamani, Mahdi ^a,c   Mehri, M ^a   Kollaee, A ^a   Yenki, P ^a   Ghaffarpor, M ^a   Harirchian, M H ^a   Shahbazi, M ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer genetics; Alzheimer therapy; APOE4; Apolipoproteins; Genetic association; Presenilin; PS2

Indexed keywords

APOENZYME; PROTEIN PS2; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS;

EID: 84988428066     PISSN: 16645464     EISSN: None     Source Type: Journal    
DOI: 10.1159/000329514     Document Type: Article

References (33)